Disparities in Access to Epilepsy Surgery Care in Children with Drug-resistant Epilepsy: Implications for Long-term Survival Outcomes
Abstract number :
3.375
Submission category :
13. Health Services (Delivery of Care, Access to Care, Health Care Models)
Year :
2023
Submission ID :
1025
Source :
www.aesnet.org
Presentation date :
12/4/2023 12:00:00 AM
Published date :
Authors :
Presenting Author: Sandi Lam, MD MBA – Lurie Children's Hospital/Northwestern University Feinberg School of Medicine
Matt Hall, PhD – Children's Hospital Association; Lu Zhang, PhD – Lurie Children's Hospital
Rationale:
Our recent publication in Lancet Child and Adolescent Health examined long-term survival rates for pediatric patients with drug-resistant epilepsy (DRE) treated with antiseizure medications (ASMs) only, ASMs plus vagus nerve stimulation (VNS), and ASMs plus cranial epilepsy surgery in a large United States (US) administrative database. The difference in survival probabilities was statistically significant (p< .001). Adjusted probabilities of survival beyond 10 years were 89.27% for the ASMs only cohort (95%CI, 87.71%-90.85%), 92.65% for VNS cohort (95%CI, 90.62%-94.72%), and 98.45% for cranial surgery cohort (95%CI, 97.53%-99.38%). In this study, we examined factors associated with higher likelihood of receiving surgical treatment (VNS or cranial epilepsy surgery).
Health Services (Delivery of Care, Access to Care, Health Care Models)